PL3044229T3 - Peptydy do zastosowania w leczeniu zapalenia błony śluzowej jamy ustnej - Google Patents
Peptydy do zastosowania w leczeniu zapalenia błony śluzowej jamy ustnejInfo
- Publication number
- PL3044229T3 PL3044229T3 PL14844276.7T PL14844276T PL3044229T3 PL 3044229 T3 PL3044229 T3 PL 3044229T3 PL 14844276 T PL14844276 T PL 14844276T PL 3044229 T3 PL3044229 T3 PL 3044229T3
- Authority
- PL
- Poland
- Prior art keywords
- peptides
- treatment
- oral mucositis
- mucositis
- oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361877767P | 2013-09-13 | 2013-09-13 | |
| PCT/US2014/050516 WO2015038264A1 (en) | 2013-09-13 | 2014-08-11 | Novel peptides and analogs for use in the treatment of oral mucositis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3044229T3 true PL3044229T3 (pl) | 2024-03-25 |
Family
ID=52666140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14844276.7T PL3044229T3 (pl) | 2013-09-13 | 2014-08-11 | Peptydy do zastosowania w leczeniu zapalenia błony śluzowej jamy ustnej |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US9850279B2 (pl) |
| EP (1) | EP3044229B1 (pl) |
| JP (2) | JP6645968B2 (pl) |
| KR (3) | KR102483333B1 (pl) |
| CN (1) | CN105722852B (pl) |
| AU (3) | AU2014318247B2 (pl) |
| BR (1) | BR112016005557B1 (pl) |
| CA (1) | CA2923553C (pl) |
| DK (1) | DK3044229T3 (pl) |
| ES (1) | ES2965906T3 (pl) |
| FI (1) | FI3044229T3 (pl) |
| HR (1) | HRP20231652T1 (pl) |
| HU (1) | HUE066502T2 (pl) |
| IL (1) | IL244573B (pl) |
| LT (1) | LT3044229T (pl) |
| MX (1) | MX382364B (pl) |
| MY (1) | MY177930A (pl) |
| NZ (2) | NZ756128A (pl) |
| PL (1) | PL3044229T3 (pl) |
| PT (1) | PT3044229T (pl) |
| RU (1) | RU2668963C2 (pl) |
| SG (1) | SG11201601891XA (pl) |
| WO (1) | WO2015038264A1 (pl) |
| ZA (2) | ZA201601967B (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9808438B2 (en) * | 2015-11-09 | 2017-11-07 | Enzychem Lifesciences Corporation | Method for treating mucositis |
| GB201711183D0 (en) | 2017-07-12 | 2017-08-23 | Smith & Nephew | Antimicrobial or wound care materials, devices and uses |
| MX2020008803A (es) | 2018-02-23 | 2021-01-15 | H Lee Moffitt Cancer Ct & Res | Receptores de antígenos quiméricos que se unen a cd83. |
| US20200108098A1 (en) * | 2018-02-23 | 2020-04-09 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Anti-cd83 chimeric antigen receptor expressing t regulatory cells |
| KR102192471B1 (ko) * | 2019-10-18 | 2020-12-17 | 주식회사 인코스팜 | 탈모 완화 및 모발 성장을 촉진시키는 펩타이드 및 이를 포함하는 화장료 조성물 |
| EP4221737A1 (en) | 2020-09-30 | 2023-08-09 | Biotempt B.V. | Autophagy-inhibiting peptide and organic acid salt thereof addressing issues of vascular permeability |
| US20250064890A1 (en) | 2021-08-30 | 2025-02-27 | Unichem Laboratories Limited | Protein compositions for the treatment of inflammatory diseases |
| CN115944708B (zh) * | 2021-12-28 | 2025-02-21 | 四川好医生攀西药业有限责任公司 | 三肽在制备治疗和/或预防黏膜或皮肤损伤药物中的应用 |
| US20250195604A1 (en) * | 2023-11-27 | 2025-06-19 | Soligenix, Inc. | Compositions and Methods of Treatment of Certain Vasculitis Syndromes |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2701281B2 (ja) * | 1988-01-22 | 1998-01-21 | 吉富製薬株式会社 | ピラゾロピリジン化合物 |
| US20030162706A1 (en) * | 2002-02-08 | 2003-08-28 | The Procter & Gamble Company | Angiogenesis modulating proteins |
| IL163718A0 (en) * | 2002-02-26 | 2005-12-18 | Ngstat Medical Corp | Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy |
| CN1269837C (zh) | 2002-09-02 | 2006-08-16 | 上海高科联合生物技术研发有限公司 | 一组合成抗菌肽 |
| RU2507213C2 (ru) | 2005-10-04 | 2014-02-20 | Солидженикс, Инк., | Новые пептиды для лечения и профилактики иммунопатологических заболеваний, включая лечение и профилактику инфекции посредством модулирования врожденного иммунитета |
| WO2008143679A2 (en) | 2006-06-01 | 2008-11-27 | Verenium Corporation | Nucleic acids and proteins and methods for making and using them |
| JP2010505395A (ja) * | 2006-10-04 | 2010-02-25 | イニメックス ファーマシューティカルズ インコーポレイテッド | 先天免疫を調節することによる感染の処置および予防を含む、免疫関連疾患障害の処置および予防のための新規ペプチド |
| CN101578368A (zh) * | 2006-10-04 | 2009-11-11 | 伊尼梅克斯制药公司 | 包括通过调节先天免疫治疗和预防感染在内的治疗和预防免疫相关疾病的新型肽 |
| EP2373160B1 (en) * | 2008-12-08 | 2017-10-25 | Soligenix, Inc. | Topically active steroids for use in radiation injury |
| BRPI1013179A2 (pt) * | 2009-03-30 | 2019-09-24 | Prometheus Laboratories Inc | peptídeo sintético, métodos para detectar um anticorpo de proteína anti-citrulinado em uma amostra biológica, para realizar um ensaio para ajudar no diagnóstico ou prognóstico de artrite reumatóide, para melhorar a sensibilidade de diagnosticar ou prognosticar artrite reumatóide, ensaio para diagnosticar ou prognosticar artrite reumatóide, kit, e, método para identificar um peptídeo que é imunologicamente reativo com um anticorpo de proteína anti-citrulinado |
| CN102286073B (zh) * | 2011-06-27 | 2013-09-11 | 华中科技大学同济医学院附属同济医院 | 一种与牙釉质表面轴向特异性结合的七肽及其应用 |
| US20150148304A1 (en) * | 2013-10-24 | 2015-05-28 | Soligenix, Inc. | Novel Peptides and Analogs for Use in the Treatment of Macrophage Activation Syndrome |
| KR101742069B1 (ko) * | 2013-10-25 | 2017-05-31 | (주)연우 | 리필이 가능한 압출식 앰플용기 |
-
2014
- 2014-08-11 KR KR1020217029666A patent/KR102483333B1/ko active Active
- 2014-08-11 BR BR112016005557-8A patent/BR112016005557B1/pt active IP Right Grant
- 2014-08-11 PL PL14844276.7T patent/PL3044229T3/pl unknown
- 2014-08-11 EP EP14844276.7A patent/EP3044229B1/en active Active
- 2014-08-11 SG SG11201601891XA patent/SG11201601891XA/en unknown
- 2014-08-11 HU HUE14844276A patent/HUE066502T2/hu unknown
- 2014-08-11 MX MX2016003092A patent/MX382364B/es unknown
- 2014-08-11 DK DK14844276.7T patent/DK3044229T3/da active
- 2014-08-11 MY MYPI2016000451A patent/MY177930A/en unknown
- 2014-08-11 JP JP2016541974A patent/JP6645968B2/ja active Active
- 2014-08-11 CA CA2923553A patent/CA2923553C/en active Active
- 2014-08-11 ES ES14844276T patent/ES2965906T3/es active Active
- 2014-08-11 FI FIEP14844276.7T patent/FI3044229T3/fi active
- 2014-08-11 KR KR1020167009699A patent/KR20160058845A/ko not_active Ceased
- 2014-08-11 PT PT148442767T patent/PT3044229T/pt unknown
- 2014-08-11 WO PCT/US2014/050516 patent/WO2015038264A1/en not_active Ceased
- 2014-08-11 RU RU2016110153A patent/RU2668963C2/ru active
- 2014-08-11 US US15/021,889 patent/US9850279B2/en active Active
- 2014-08-11 LT LTEPPCT/US2014/050516T patent/LT3044229T/lt unknown
- 2014-08-11 NZ NZ756128A patent/NZ756128A/en unknown
- 2014-08-11 CN CN201480062073.1A patent/CN105722852B/zh active Active
- 2014-08-11 KR KR1020217010249A patent/KR102304906B1/ko active Active
- 2014-08-11 AU AU2014318247A patent/AU2014318247B2/en active Active
- 2014-08-11 NZ NZ71853414A patent/NZ718534A/en unknown
- 2014-08-11 HR HRP20231652TT patent/HRP20231652T1/hr unknown
-
2016
- 2016-03-13 IL IL244573A patent/IL244573B/en active IP Right Grant
- 2016-03-22 ZA ZA2016/01967A patent/ZA201601967B/en unknown
-
2017
- 2017-12-20 US US15/848,746 patent/US10253068B2/en active Active
-
2018
- 2018-08-13 AU AU2018214160A patent/AU2018214160B2/en active Active
-
2019
- 2019-04-11 JP JP2019075940A patent/JP2019142910A/ja active Pending
-
2020
- 2020-05-25 AU AU2020203410A patent/AU2020203410A1/en not_active Abandoned
-
2022
- 2022-08-19 ZA ZA2022/09308A patent/ZA202209308B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL245744A0 (en) | Therapeutic peptides | |
| GB201320729D0 (en) | Therapeutic compounds and their use | |
| SG10201709090UA (en) | Sobetirome in the treatment of myelination diseases | |
| SG11201506766PA (en) | Therapeutic peptides | |
| SG11201508469YA (en) | Therapeutic peptides | |
| LT3044229T (lt) | Peptidai, skirti panaudoti gydant burnos mukozitą | |
| GB201307238D0 (en) | Hair treatment kit | |
| GB201311361D0 (en) | Compounds and their therapeutic use | |
| SG11201510021TA (en) | Compositions and methods for use in medical diagnosis | |
| IL240701A0 (en) | kntc2 peptides and components containing them | |
| ZA201508050B (en) | Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias | |
| SG11201510713VA (en) | Dental treatment device | |
| GB201404355D0 (en) | Improvements in surgical instruments | |
| PL2943215T3 (pl) | Peptydy pochodzące z laktoferycyny do zastosowania w leczeniu nowotworu | |
| SG11201508529RA (en) | Skin cleansing composition | |
| GB201308736D0 (en) | Compounds and their therapeutic use | |
| GB201307872D0 (en) | Medical use | |
| GB201320506D0 (en) | Cyclic amino compounds for the use in the treatment of cardiac disorders | |
| GB201302954D0 (en) | Dental instrument | |
| GB201314623D0 (en) | Novel mucinase for use in therapy or prophylaxis | |
| GB201319004D0 (en) | Medical use | |
| GB201311290D0 (en) | Medical use | |
| GB201317804D0 (en) | Therapeutic compounds and their use | |
| GB201316173D0 (en) | Compounds and their therapeutic use | |
| GB201307677D0 (en) | Compounds and their therapeutic use |